Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning
03 juin 2021 07h30 HE
|
Auris Medical AG
Entering field of RNA therapeutics through acquisition of Trasir Therapeutics, Inc.Trasir’s innovative peptide-based OligoPhoreTM platform designed to enable extrahepatic delivery of...